R&D Department, Lo.Li. Pharma Srl, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):438-446. doi: 10.26355/eurrev_202101_24412.
D-chiro-Inositol has been widely used in clinical practice to induce ovulation in women with polycystic ovary syndrome. Only recent evidence established that this molecule acts through two different mechanisms, with potentially different outcomes. On the one hand, under a metabolic perspective, D-chiro-Inositol improves insulin signaling, thus restoring physiological insulin levels in resistant subjects. On the other hand, at a cellular level, it downregulates the expression of steroidogenic enzyme aromatase, which is responsible for the conversion of androgens to estrogens.
We reviewed current literature in different databases, searching for D-chiro-Inositol in relation with one of the following keywords: myo-inositol, PCOS, infertility, insulin resistance, aromatase, androgen and inositol, testosterone, estrogen and inositol, estradiol, hypogonadotropic hypogonadism, fat tissue, estrogens and cancer, anovulation, uterine myoma, endometriosis, endometrial hyperplasia.
D-Chiro-Inositol treatment may be helpful in restoring physiological hormonal levels in various clinical disorders. However, D-Chiro-Inositol intervention should be carefully designed to avoid possible undesired side effects stemming from its multiple mechanisms of action.
We evaluated the optimal D Chiro-Inositol administration for different pathologies, defining dosages and timing. Even though further studies are required to validate our preliminary results, this paper is primarily intended to guide researchers through some of the pathways of D-Chiro-Inositol.
D-手性肌醇已广泛用于临床实践中,以诱导多囊卵巢综合征女性排卵。只有最近的证据表明,这种分子通过两种不同的机制起作用,可能有不同的结果。一方面,从代谢的角度来看,D-手性肌醇改善胰岛素信号,从而恢复抵抗性患者的生理胰岛素水平。另一方面,在细胞水平上,它下调了合成酶芳香酶的表达,芳香酶负责将雄激素转化为雌激素。
我们在不同的数据库中回顾了当前的文献,搜索与以下关键词之一有关的 D-手性肌醇:肌醇、多囊卵巢综合征、不孕、胰岛素抵抗、芳香酶、雄激素和肌醇、睾丸激素、雌激素和肌醇、雌二醇、促性腺激素缺乏性性腺功能减退症、脂肪组织、雌激素和癌症、排卵障碍、子宫肌瘤、子宫内膜异位症、子宫内膜增生。
D-手性肌醇治疗可能有助于恢复各种临床疾病的生理激素水平。然而,D-手性肌醇的干预应仔细设计,以避免其多种作用机制可能产生的不良副作用。
我们评估了不同病理情况下 D 手性肌醇的最佳给药剂量和时间。尽管还需要进一步的研究来验证我们的初步结果,但本文主要旨在通过 D-手性肌醇的一些途径为研究人员提供指导。